These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26219859)

  • 21. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
    Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
    Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
    Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
    Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
    Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amphiphilic polymer-mediated formation of laponite-based nanohybrids with robust stability and pH sensitivity for anticancer drug delivery.
    Wang G; Maciel D; Wu Y; Rodrigues J; Shi X; Yuan Y; Liu C; Tomás H; Li Y
    ACS Appl Mater Interfaces; 2014 Oct; 6(19):16687-95. PubMed ID: 25167168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination prostate cancer therapy: Prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone.
    Sun G; Sun K; Sun J
    Drug Deliv; 2021 Dec; 28(1):1132-1140. PubMed ID: 34121558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved delivery of doxorubicin using rationally designed PEGylated platinum nanoparticles for the treatment of melanoma.
    Mukherjee S; Kotcherlakota R; Haque S; Bhattacharya D; Kumar JM; Chakravarty S; Patra CR
    Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110375. PubMed ID: 31924026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BSA-based Cu
    Liu Z; Chan L; Ye X; Bai Y; Chen T
    Colloids Surf B Biointerfaces; 2018 Dec; 172():298-307. PubMed ID: 30173097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small Peptide-Doxorubicin Co-Assembly for Synergistic Cancer Therapy.
    Li S; Chen X; Chen H; Peng J; Yang X
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31979298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new combination strategy to enhance apoptosis in cancer cells by using nanoparticles as biocompatible drug delivery carriers.
    Kucuksayan E; Bozkurt F; Yilmaz MT; Sircan-Kucuksayan A; Hanikoglu A; Ozben T
    Sci Rep; 2021 Jun; 11(1):13027. PubMed ID: 34158544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanospherical arabinogalactan proteins are a key component of the high-strength adhesive secreted by English ivy.
    Huang Y; Wang Y; Tan L; Sun L; Petrosino J; Cui MZ; Hao F; Zhang M
    Proc Natl Acad Sci U S A; 2016 Jun; 113(23):E3193-202. PubMed ID: 27217558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells.
    Haque ST; Islam RA; Gan SH; Chowdhury EH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817
    [No Abstract]   [Full Text] [Related]  

  • 33. Co-delivery of DOX and PDTC by pH-sensitive nanoparticles to overcome multidrug resistance in breast cancer.
    Cheng X; Li D; Sun M; He L; Zheng Y; Wang X; Tang R
    Colloids Surf B Biointerfaces; 2019 Sep; 181():185-197. PubMed ID: 31132609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
    Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
    Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a novel biocompatible magnetic nanomedicine based on beta-cyclodextrin, loaded doxorubicin-curcumin for overcoming chemoresistance in breast cancer.
    Rastegar R; Akbari Javar H; Khoobi M; Dehghan Kelishadi P; Hossein Yousefi G; Doosti M; Hossien Ghahremani M; Shariftabrizi A; Imanparast F; Gholibeglu E; Gholami M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):207-216. PubMed ID: 29688063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumors.
    Ramasamy T; Ruttala HB; Chitrapriya N; Poudal BK; Choi JY; Kim ST; Youn YS; Ku SK; Choi HG; Yong CS; Kim JO
    Acta Biomater; 2017 Jan; 48():131-143. PubMed ID: 27794477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bio-synthesis of gold nanoparticles using English ivy (Hedera helix).
    Yi S; Xia L; Lenaghan SC; Sun L; Huang Y; Burris JN; Stewart CN; Zhang M
    J Nanosci Nanotechnol; 2013 Mar; 13(3):1649-59. PubMed ID: 23755570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release.
    Pan YJ; Chen YY; Wang DR; Wei C; Guo J; Lu DR; Chu CC; Wang CC
    Biomaterials; 2012 Sep; 33(27):6570-9. PubMed ID: 22704845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.